Clinical Trial Update: Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) [NA]

View source ↗

Summary

Clinical trial CHOICE-2 is evaluating intrathoracic chemotherapy for thymic epithelial tumors with pleural spread or recurrence; the study is currently not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Epithelial Tumor

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Thymic Epithelial Tumor | NA | Status: NOT_YET_RECRUITING